August 14, 2025
Limited Art Edition 2025
2025 TAG Limited Art Edition Picture of framed version will be forthcoming Matthew Leifheit George Platt Lynes Scrapbook Pages 2025 Photogravure with chine-collé Print dimensions: 16 x 20 inches Framed dimensions: 18 x 22 inches Edition: 40, 4 A/Ps
August 13, 2025
2025 Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
July 28, 2025
HCV Storyboard: Sibusiso Dlamini
This Hepatitis C virus (HCV) storyboard describes the experience of Sibusiso Dlamini in Tsawne, South Africa. Sibusiso is a young man who began using substances for leisure in high school, and later in life switched to injecting substances for a stronger high.
July 10, 2025
An Activist’s Guide to Diagnostic Tools for Tuberculosis 2025
The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs.
July 8, 2025
2024 Annual Report
I’m proud to share with you TAG’s 2024 Annual Report. Last year already seems long ago with all the attacks on research and health care, domestic and international, which are currently taking place under the new administration…
July 3, 2025
Brick by Brick: A Brief Guide to Protecting Your Community’s Health with Direct Action
TAG’s Senior TB Project Associate, Erin McConnell, created this ‘zine about TAG for Pride 2025. It’s about fighting back, and goes over current threats, action items, and action steps on how to show up.
May 30, 2025
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
This publication discusses findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on, and the facilitators and barriers to potential long-acting therapies for Hepatitis C virus (HCV) cure currently being developed by the LONGEVITY consortium, funded by the global health agency Unitaid.
May 15, 2025
South Africa’s TB and HIV Research at Risk: A Call to Catalyze Urgent Action by Funders
Developed by TAG, Médecins Sans Frontières, and the South African Medical Research Council, this issue brief provides information about TB and HIV clinical trials and research programs impacted by U.S. government funding disruptions…
May 1, 2025
NIH Advocacy Toolkit for HIV & TB Researchers
The Research Matters Advocacy Toolkit is a vital resource for researchers committed to advancing health equity and biomedical advocacy.